DE2900656A1 - Chromonderivate, verfahren zu deren herstellung und sie enthaltende arzneimittel - Google Patents

Chromonderivate, verfahren zu deren herstellung und sie enthaltende arzneimittel

Info

Publication number
DE2900656A1
DE2900656A1 DE19792900656 DE2900656A DE2900656A1 DE 2900656 A1 DE2900656 A1 DE 2900656A1 DE 19792900656 DE19792900656 DE 19792900656 DE 2900656 A DE2900656 A DE 2900656A DE 2900656 A1 DE2900656 A1 DE 2900656A1
Authority
DE
Germany
Prior art keywords
france
chromone
chickens
derivatives
manufacturing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
DE19792900656
Other languages
German (de)
English (en)
Other versions
DE2900656C2 (de
Inventor
Henri Chibret
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Thea Therapeutique & Applicat
Original Assignee
Thea Therapeutique & Applicat
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR7801154A external-priority patent/FR2414506A1/fr
Application filed by Thea Therapeutique & Applicat filed Critical Thea Therapeutique & Applicat
Publication of DE2900656A1 publication Critical patent/DE2900656A1/de
Application granted granted Critical
Publication of DE2900656C2 publication Critical patent/DE2900656C2/de
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/06Antigout agents, e.g. antihyperuricemic or uricosuric agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DE2900656A 1978-01-17 1979-01-10 2-(3'-Brom-4'-hydroxybenzoyl)- und 2-(3',5'-Dibrom-4'-hydroxybenzoyl)-chromone, Verfahren zu deren Herstellung und diese enthaltende Arzneimittel Expired DE2900656C2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR7801154A FR2414506A1 (fr) 1978-01-17 1978-01-17 Nouvelle chromone a activite medicamenteuse
FR7836421A FR2445326A2 (fr) 1978-01-17 1978-12-27 Nouvelle chromone a activite medicamenteuse

Publications (2)

Publication Number Publication Date
DE2900656A1 true DE2900656A1 (de) 1979-07-19
DE2900656C2 DE2900656C2 (de) 1987-03-26

Family

ID=26220400

Family Applications (1)

Application Number Title Priority Date Filing Date
DE2900656A Expired DE2900656C2 (de) 1978-01-17 1979-01-10 2-(3'-Brom-4'-hydroxybenzoyl)- und 2-(3',5'-Dibrom-4'-hydroxybenzoyl)-chromone, Verfahren zu deren Herstellung und diese enthaltende Arzneimittel

Country Status (4)

Country Link
JP (1) JPS54112871A (it)
DE (1) DE2900656C2 (it)
FR (1) FR2445326A2 (it)
IT (1) IT1166579B (it)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1426378A1 (de) * 2002-12-02 2004-06-09 MERCK PATENT GmbH 2-Benzoylchromonderivate

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
NICHTS-ERMITTELT *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1426378A1 (de) * 2002-12-02 2004-06-09 MERCK PATENT GmbH 2-Benzoylchromonderivate

Also Published As

Publication number Publication date
IT7919312A0 (it) 1979-01-16
FR2445326A2 (fr) 1980-07-25
JPS6160837B2 (it) 1986-12-23
FR2445326B2 (it) 1981-02-27
DE2900656C2 (de) 1987-03-26
JPS54112871A (en) 1979-09-04
IT1166579B (it) 1987-05-05

Similar Documents

Publication Publication Date Title
DE2902297C2 (it)
DE69012268T2 (de) Mittel zur Hemmung der alpha-Amylase Aktivität.
DE2709820C2 (de) N-(Mercaptoacyl)-L oder DL-cysteine, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende mucolytische Mittel
DD146893A1 (de) Verfahren zur herstellung von cyclodextrin-kamillen-inklusionskomplexen
EP0034784A1 (de) Derivate des 3,4,5-Trihydroxypiperidins, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel sowie in der Tierernährung
DE2839309A1 (de) 3,4,5-trihydroxypiperidin-derivate
DE3721206A1 (de) Melatonin-derivate, ihre herstellung und sie enthaltende arzneimittel
DE2522090A1 (de) Pyrimidinol-verbindungen und verfahren zu ihrer herstellung
Anderson Nucleic acid derivatives in soils
DE2900656A1 (de) Chromonderivate, verfahren zu deren herstellung und sie enthaltende arzneimittel
DE2314478B2 (de) 3-Substituierte Rifamycin-SV-derivate, Verfahren zu ihrer Herstellung und therapeutische Zubereitung, die diese Verbindungen enthält
DE3634496C2 (de) Glukosylmoranolinderivate und ihre Herstellung
EP0010745B1 (de) Derivate des 2-Hydroxymethyl-3,4,5-trihydroxy-piperidins, ihre Herstellung und sie enthaltende Arzneimittel
DE2150593A1 (de) Neues Antibiotikum WS-4545 und dessen Derivate
DE3204630C2 (it)
DE2243777A1 (de) Dihydrochinolinderivate, ihre verwendung und verfahren zur herstellung derselben
DE2028880C3 (de) N-Phenylcarbamoyl-3-(ßphenylisopropyl)sydnonunin, Verfahren zu dessen Herstellung und Arzneimittel
EP0022213A1 (de) Benzothiazol-2(3H)-one-Derivate enthaltende Arzneimittel
DE2522047A1 (de) Pharmazeutisches mittel zum induzieren von interferon
CH640244A5 (en) Biologically active substance
DE69902866T2 (de) Extrakte aus kuhausscheidungen mit antikrebs- und antiinflammatorischer wirksamkeit sowie verfahren zu deren herstellung
DE2708493A1 (de) Neues antibiotikum am-1042
DE2302567B2 (de) 3-Substituierte Rifamycine, Verfahren zu ihrer Herstellung und therapeutische Zubereitung, die diese Verbindungen enthält
Kruse et al. Biochemical investigation of vitamin B
DE2005255C3 (de) Verwendung von Ca-5-butylpicolinat und/oder Ca-5-pentylpicolinat zur Herstellung eines blutdrucksenkenden Arzneimittels

Legal Events

Date Code Title Description
8110 Request for examination paragraph 44
D2 Grant after examination
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee